Antimicrobial Resistance Research Assessment Act of 2024
HR 7436, the Antimicrobial Resistance Research Assessment Act of 2024, requires the Comptroller General to prepare and submit a report to Congress within one year of enactment. The report must comprehensively assess all federal efforts addressing antimicrobial resistance, including interagency programs, task forces, and federally funded research, while identifying duplications and quantifying research costs. It specifically directs the report to evaluate coordination across agencies, recommend improvements, and assess phage therapy initiatives. This bill does not create new programs or funding but mandates a federal review of existing antimicrobial resistance efforts.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2024
Committee Review
Floor Vote
President
Introduced Feb 23, 2024
Last action Feb 23, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Feb 23, 2024
Committee
Referred to the Subcommittee on Health.
lower
Feb 23, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
Feb 23, 2024
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
H. Morgan Griffith
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7436
Scope: US
Hi! I can help you understand HR 7436. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline